{"id":18050,"date":"2014-05-30T03:30:00","date_gmt":"2014-05-30T01:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/roche-novartis-la-memoria-ha-le-gambe-corte-2\/"},"modified":"2014-05-30T03:30:00","modified_gmt":"2014-05-30T01:30:00","slug":"roche-novartis-la-memoria-ha-le-gambe-corte-2","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/roche-novartis-la-memoria-ha-le-gambe-corte-2\/","title":{"rendered":"Roche-Novartis, memory has short legs"},"content":{"rendered":"

Of Chiara Daina<\/span><\/span><\/a><\/span><\/b><\/span> | 30<\/span><\/a> May 2014<\/span><\/a>  The Fact Chronicle<\/p>\n

<\/span><\/span><\/b><\/p>\n

Memory has short legs. Given that it is dutiful and right <\/span><\/span>the request for compensation of 1.2 billion euros by the Ministry of Health<\/strong> to Swiss companies Roche and Novartis<\/strong><\/span><\/a> for damage caused to the National health system<\/strong>, it cannot be said that the problem of speculation by pharmaceutical companies on citizens' health is resolved. And it certainly won't even be a fine from the Antitrust (<\/span>the 180 million euro one that the two Swiss giants got themselves last March<\/span><\/span><\/a>) to prevent that Big Pharma<\/strong> you keep making profit on people's life and death. It didn't help <\/span>fine Pfizer 10.6 million euros in 2012<\/span><\/span><\/a> for creating the monopoly of latanoprost, the molecule for the glaucoma treatment<\/strong>. Nor to force the American company to compensate the Italian state by paying out 14 million euros<\/strong>. Also useless <\/span>US fine imposed $2.3 billion in 2009 for Bextra<\/span><\/span><\/a>, an anti-inflammatory, which was later withdrawn from the market. <\/span>A series of other stratospheric fines have been worth very little<\/span><\/span><\/a>: the one from <\/span>$1.4 billion apiece Eli Lilly<\/strong><\/span><\/a> for having illegally marketed an antipsychotic, Zyprexa, with harmful effects (2009); the one from <\/span>di Chiara Daina | 30 maggio 2014  Il Fatto Cronaca La memoria ha le gambe corte. Premesso che è doverosa e giusta la richiesta del risarcimento di 1,2 miliardi di euro da parte del ministero della Salute alle società svizzere Roche e Novartis per i danni causati al Sistema sanitario nazionale, non si può dire …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-18050","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=18050"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18050\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=18050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=18050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=18050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}